Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A ten-year comparison of Aristocrats ETFs highlights performance patterns, dividend consistency, and growth trajectory to aid selection.
27,377 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Uniswap activated its fee switch today, enabling on-chain UNI buybacks funded by protocol fees. The move links revenu...
Two lawsuits over Anywhere Real Estate’s homebuyer commissions collide in Illinois courts as plaintiffs seek to conso...
Apple’s latest product lineup signals more than new gadgets—it signals a large-scale AI strategy. This article breaks...
here thursday’s wall street mood shifts as fresh analyst notes touch on Astera Labs, Block, Digital Realty and others...
Tariffs grabbed headlines, but markets can react to other forces just as sharply. This guide breaks down two addition...
A major fundraise for the Zcash Open Development Lab is fueling rapid progress for privacy technology. This piece exp...
Goodyear’s stock surged intraday as oil prices pulled back and demand expectations shifted. Learn what drove the move...
Chewy rode a brighter sales outlook to a rally in its stock, with the company signaling durable demand for pet care d...
Ondas stock moved sharply higher after a strong Q1 revenue beat and higher full-year guidance. This piece breaks down...
Cisco and CrowdStrike rally prompt debate on which name makes the better short bet. The case centers on Cisco's margi...
Get ready for the genk 2025 earnings call with a clear game plan. This guide breaks down what to listen for, how to r...